Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.

[1]  F. Blankenberg,et al.  Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m. , 2008, Bioconjugate chemistry.

[2]  Marina V Backer,et al.  Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes , 2007, Nature Medicine.

[3]  K. Claffey,et al.  Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. , 2006, Biomaterials.

[4]  K. Claffey,et al.  Inhibition of Anthrax Protective Antigen Outside and Inside the Cell , 2006, Antimicrobial Agents and Chemotherapy.

[5]  Vimalkumar A. Patel,et al.  Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). , 2006, Bioconjugate chemistry.

[6]  V. Ntziachristos Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[7]  M. Backer,et al.  Self-assembled "dock and lock" system for linking payloads to targeting proteins. , 2006, Bioconjugate chemistry.

[8]  Vimalkumar A. Patel,et al.  In vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  T. Allen,et al.  Ligand-targeted liposomes for cancer treatment. , 2005, Current drug delivery.

[10]  K. Claffey,et al.  Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature , 2005, Molecular Cancer Therapeutics.

[11]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[12]  Theresa M Allen,et al.  Advantages of liposomal delivery systems for anthracyclines. , 2004, Seminars in oncology.

[13]  R. Weissleder,et al.  Fluorescence molecular imaging of small animal tumor models. , 2004, Current molecular medicine.

[14]  E. Moase,et al.  ADVENTURES IN TARGETING , 2002, Journal of liposome research.

[15]  F. Blankenberg,et al.  Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. , 2000, Bioconjugate chemistry.